Molecular defects in the α-N-acetylglucosaminidase gene in Italian Sanfilippo type B patients

A. Tessitore, G. R D Villani, C. Di Domenico, M. Filocamo, R. Gatti, NataleP Di

Research output: Contribution to journalArticlepeer-review


Sanfilippo syndrome type B (mucopolysaccharidosis IIIB) is a rare autosomal recessive disorder characterized by the inability to degrade heparan sulfate because of a deficiency of the lysosomal enzyme α-N-acetylglucosaminidase (NAGLU). We performed mutation screening in a group of 20 patients, identifying 28 mutations, 14 of which were novel (L35F, 204delC, 221insGCGCG, G82D, W156C, 507delC, IVS3+1G→A, E336X, V501G, R520W, S534Y, W649C, 1953insGCCA, 2185delAGA). Four of these mutations were found in homozygosity and only one was seen in two different patients, showing the remarkable molecular heterogeneity of the disease. Mutation IVS3+1G→A produces aberrant RNA splicing: it represents a base substitution from G to A of the invariant GT dinucleotides at the splicing donor site of intron 3 resulting in the skipping of exon 3 and both exons 2 and 3. Transient transfection of COS cells, by DNA mutagenized with NAGLU mutations, produced enzymatic molecules without activity, demonstrating the deleterious nature of the defects. Metabolic labeling of transfected mutants suggested a normal synthesis of the involved polypeptide for missense alterations, whereas increased protein or mRNA instability was shown for nonsense and most of the frameshift mutations.

Original languageEnglish
Pages (from-to)568-576
Number of pages9
JournalHuman Genetics
Issue number6
Publication statusPublished - 2000

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics


Dive into the research topics of 'Molecular defects in the α-N-acetylglucosaminidase gene in Italian Sanfilippo type B patients'. Together they form a unique fingerprint.

Cite this